✦ LIBER ✦

Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma

✍ Scribed by Forero-Torres, Andres; Bartlett, Nancy; Beaven, Anne; Myint, Han; Nasta, Sunita; Northfelt, Donald W.; Whiting, Nancy C.; Drachman, Jonathan G.; LoBuglio, Albert F.; Moskowitz, Craig H.

Book ID: 118026350
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 269 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2012.710328

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab, gemcitabine, cisplatin, and d

Rituximab, gemcitabine, cisplatin, and dexamethasone in patients with refractory or relapsed aggressive B-cell lymphoma

✍ Yun Hou, Hua-qing Wang, Yi Ba 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 369 KB

Combination of Lenalidomide and Rituxima

Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial

✍ Pier Luigi Zinzani; Cinzia Pellegrini; Letizia Gandolfi; Vittorio Stefoni; Feder 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 281 KB

Bortezomib in combination with rituximab

Bortezomib in combination with rituximab, dexamethasone, ifosfamide, cisplatin and etoposide chemoimmunotherapy in patients with relapsed and primary refractory diffuse large B-cell lymphoma

✍ Elstrom, Rebecca L.; Andemariam, Biree; Martin, Peter; Ruan, Jia; Shore, Tsipora 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 224 KB

Feasibility and pharmacokinetic study of

Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin’s lymphoma

✍ Michinori Ogura; Kiyoshi Ando; Masafumi Taniwaki; Takashi Watanabe; Toshiki Uchi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Phase 2 study of gemcitabine in combinat

Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma

✍ Yasuhiro Oki; Barbara Pro; Luis E. Fayad; Jorge Romaguera; Felipe Samaniego; Fre 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

## Abstract ## BACKGROUND. The management of recurrent or refractory Hodgkin lymphoma (HL) remains challenging. The objective of this phase 2 trial was to investigate the activity of gemcitabine in combination with rituximab in patients with recurring or refractory HL. ## METHODS. Patients were

Combination chemotherapy with gemcitabin

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group

✍ Efstathios S. Papageorgiou; Panagiotis Tsirigotis; Meletios Dimopoulos; Nikolaos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB